Header graphic for print
FDA Life News and Trends Impacting the FDA and Life Science Industry

Category Archives: Healthcare

Subscribe to Healthcare RSS Feed

Susan Winckler Featured Keynote Speaker This Week at 8th Annual Pharmaceutical and Medical Device Conference in Chicago on November 10

Posted in Advertising and Promotion, Animal Drugs, Antitrust, Biological Products, Clinical Studies, Drugs, Emerging Growth, Enforcement, European Union, FDA Organization, Healthcare, Intellectual Property, Legislation, Litigation, Medical Devices, Meetings, Patents, Regulation

159161119On November 10, 2016, McGuireWoods LLP and McGuireWoods Consulting (“McGuireWoods”) will be holding its 8th Annual Pharmaceutical and Medical Device Conference in Chicago.  Kicking off the Conference will be Keynote Speaker, Susan Winckler, the Chief Risk Management Officer for Continue Reading

NYSBA Food, Drug and Cosmetic Section Annual Meeting Features Medical Device Advertising (FDA and FTC), Laboratory Developed Tests, Attorney Ethics Representing Medical Marijuana Clients, and Important Case Updates Featuring New York’s Chief of the Antitrust Bureau

Posted in Advertising and Promotion, Drugs, Enforcement, Generic Drugs, Healthcare, Legislation, Litigation, Medical Devices, Meetings

On January 29, 2015, the Food, Drug and Cosmetic Law Section (FDC Section) of the New York State Bar Association (NYSBA) will hold its Annual Meeting at the New York Hilton Midtown, New York City.  This year’s meeting includes a Continue Reading

FDA/CMS Summit Demonstrates Increasing Importance for Parallel Review Considerations and Ongoing FDA and CMS Reform – Part 2 of 2

Posted in Biological Products, Biosimilars, Drugs, Healthcare, Medicare, Meetings, Reimbursement

On December 11-12, 2014, Informa Business Information, Inc. presented its 10th Annual FDA/CMS Summit.  The Summit delivered presentations from key leaders in both the FDA and Centers for Medicare and Medicaid (CMS) sectors with many thought-provoking discussions.  Some of those Continue Reading

FDA/CMS Summit Demonstrates Increasing Importance for Parallel Review Considerations and Ongoing FDA and CMS Reform – Part 1 of 2

Posted in Biological Products, Drugs, Healthcare, Medicare, Meetings, Reimbursement

On December 11-12, 2014, Informa Business Information, Inc. presented its 10th Annual FDA/CMS Summit.  The Summit delivered presentations from key leaders in both the FDA and Centers for Medicare and Medicaid (CMS) sectors with many thought-provoking discussions.  Some of those Continue Reading